Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway

NCT01967160 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01967160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01967160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Pharmacovigilance Study of Osteonecrosis of the Jaw and Infection Leading to Hospitalization Among Patients With Cancer Treated With XGEVA™ or Zoledronic Acid in Sweden, Denmark, and Norway
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
January 2, 2012
Completion date
August 5, 2019
Enrollment
2,560 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infection leading to hospitalization, osteonecrosis of the jaw